BWAY.US Brainsway Ltd

Healthcare Health Care Equipment & Supplies USA Stocks
10.11 USD
Close of Nov 14, 2026
7.14 17.40
Market cap
USD 407M
P/E
42.1x
P/B
5.02x
ROE
11.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BWAY.US undervalued?

Graham number

The Graham number of Brainsway Ltd cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Brainsway Ltd fundamental analysis

No fundamental analysis for Brainsway Ltd yet.

Brainsway Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Brainsway Ltd

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, po…

Full company profile